Search - tctmd.com

Displaying 1 - 20 of 38

Sort: Relevancy | Date

Electrical Variables, Not Valve Type, Predict Need for Pacemaker After TAVI

Michael O'Riordan

December 02, 2024

News Conference News PCR London Valves 2024

Newest Sapien TAVI Equals Surgery in Patients With Small Aortic Annuli at 5 Years

Michael O'Riordan

November 27, 2024

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

L.A. McKeown

November 26, 2024

News Conference News PCR London Valves 2024

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

Michael O'Riordan

November 25, 2024

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

L.A. McKeown

November 01, 2024

Presentation TCT 2024

The Rise of AHA Target: Aortic Stenosis – Applying Quality Improvement Upstream of the Procedure (in partnership with the American Heart Association)

Presenter: Brian Lindman

October 30, 2024

Presentation TCT 2024

Late Clinical Outcomes in Small Annulus Patients in the PARTNER Trials

Presenter: Mahesh Madhavan

October 30, 2024

Presentation TCT 2024

The Impact of Access Disparities on Appropriate AS Therapy and Clinical Outcomes

Presenter: David Wood

October 30, 2024

Presentation TCT 2024

Can AI-Assisted Earlier AS Diagnosis Level the Disparities Playing Field?

Presenter: Pierre Elias

October 30, 2024

Presentation TCT 2024

Impact of Delays in Diagnosis and Treatment: Join the AHA TARGET AS Program!

Presenter: Brian Lindman

October 30, 2024

Presentation TCT 2024

Patient Perspectives and Shared Decision-Making in Younger Patients Requiring AS Therapy

Presenter: Megan Coylewright

October 30, 2024

Presentation TCT 2024

Surgical Valve Selection in Younger Patients with AS: Mechanical, Bioprosthetic, or Ross?

Presenter: Katherine Harrington

October 30, 2024

Presentation TCT 2024

The Emerging Use of TAVR in Younger Patients: Updates and Evidence Gaps

Presenter: Harold Dauerman

October 30, 2024

Presentation TCT 2024

Transcatheter vs. Surgical Aortic Valve Replacement in Women: A Pooled Analysis of the RHEIA and PARTNER 3 Trials

Presenter: Didier Tchetche

October 29, 2024

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Industry News

Pi-Cardia Receives FDA Market Clearance for ShortCut™

October 01, 2024

News Conference News ESC 2024

Balloon-Expandable TAVI Superior to SAVR in Women at 1 Year: RHEIA

Caitlin E. Cox

September 04, 2024

News Features

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

L.A. McKeown

August 09, 2024

News Daily News

Knowns and Unknowns in Subclinical Aortic Valve Thrombosis

Caitlin E. Cox

June 21, 2024

Advertisement

Electrical Variables, Not Valve Type, Predict Need for Pacemaker After TAVI

Newest Sapien TAVI Equals Surgery in Patients With Small Aortic Annuli at 5 Years

November 2024 Dispatch for the CV Team

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

The Rise of AHA Target: Aortic Stenosis – Applying Quality Improvement Upstream of the Procedure (in partnership with the American Heart Association)

Late Clinical Outcomes in Small Annulus Patients in the PARTNER Trials

The Impact of Access Disparities on Appropriate AS Therapy and Clinical Outcomes

Can AI-Assisted Earlier AS Diagnosis Level the Disparities Playing Field?

Impact of Delays in Diagnosis and Treatment: Join the AHA TARGET AS Program!

Patient Perspectives and Shared Decision-Making in Younger Patients Requiring AS Therapy

Surgical Valve Selection in Younger Patients with AS: Mechanical, Bioprosthetic, or Ross?

The Emerging Use of TAVR in Younger Patients: Updates and Evidence Gaps

Transcatheter vs. Surgical Aortic Valve Replacement in Women: A Pooled Analysis of the RHEIA and PARTNER 3 Trials

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

What’s Going to Be Big at TCT 2024?

Pi-Cardia Receives FDA Market Clearance for ShortCut™

Balloon-Expandable TAVI Superior to SAVR in Women at 1 Year: RHEIA

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

Knowns and Unknowns in Subclinical Aortic Valve Thrombosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content